BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17088077)

  • 1. Effects of small interference RNA against PTP1B and TCPTP on insulin signaling pathway in mouse liver: evidence for non-synergetic cooperation.
    Xu J; Li L; Hong J; Huang W
    Cell Biol Int; 2007 Jan; 31(1):88-91. PubMed ID: 17088077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter.
    Xu J; Li L; Qian Z; Hong J; Shen S; Huang W
    Biochem Biophys Res Commun; 2005 Apr; 329(2):538-43. PubMed ID: 15737620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
    Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP.
    Galic S; Hauser C; Kahn BB; Haj FG; Neel BG; Tonks NK; Tiganis T
    Mol Cell Biol; 2005 Jan; 25(2):819-29. PubMed ID: 15632081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis.
    Tiganis T
    FEBS J; 2013 Jan; 280(2):445-58. PubMed ID: 22404968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of several protein tyrosine phosphatases in diabetes].
    Chen M; Sun JP; Liu J; Yu X
    Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice.
    Vakili S; Ebrahimi SS; Sadeghi A; Gorgani-Firuzjaee S; Beigy M; Pasalar P; Meshkani R
    Mol Med Rep; 2013 Jan; 7(1):211-6. PubMed ID: 23138128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling.
    Sun T; Wang Q; Yu Z; Zhang Y; Guo Y; Chen K; Shen X; Jiang H
    Chembiochem; 2007 Jan; 8(2):187-93. PubMed ID: 17183521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatases: the quest for negative regulators of insulin action.
    Asante-Appiah E; Kennedy BP
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E663-70. PubMed ID: 12626322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
    Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
    Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms.
    Rondinone CM; Clampit J; Gum RJ; Zinker BA; Jirousek MR; Trevillyan JM
    Biochem Biophys Res Commun; 2004 Oct; 323(2):652-9. PubMed ID: 15369800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver.
    Lam NT; Covey SD; Lewis JT; Oosman S; Webber T; Hsu EC; Cheung AT; Kieffer TJ
    J Mol Endocrinol; 2006 Feb; 36(1):163-74. PubMed ID: 16461936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-tyrosine phosphatase 1B associates with insulin receptor and negatively regulates insulin signaling without receptor internalization.
    Shi K; Egawa K; Maegawa H; Nakamura T; Ugi S; Nishio Y; Kashiwagi A
    J Biochem; 2004 Jul; 136(1):89-96. PubMed ID: 15269244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose enhances protein tyrosine phosphatase 1B gene transcription in hepatocytes.
    Inada S; Ikeda Y; Suehiro T; Takata H; Osaki F; Arii K; Kumon Y; Hashimoto K
    Mol Cell Endocrinol; 2007 Jun; 271(1-2):64-70. PubMed ID: 17509747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.